annual accounts payable:
$4.57B-$354.00M(-7.19%)Summary
- As of today (May 20, 2025), NVS annual accounts payable is $4.57 billion, with the most recent change of -$354.00 million (-7.19%) on December 31, 2024.
- During the last 3 years, NVS annual accounts payable has fallen by -$981.00 million (-17.67%).
- NVS annual accounts payable is now -25.63% below its all-time high of $6.15 billion, reached on December 31, 2013.
Performance
NVS Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$4.26B-$311.00M(-6.80%)Summary
- As of today (May 20, 2025), NVS quarterly accounts payable is $4.26 billion, with the most recent change of -$311.00 million (-6.80%) on March 31, 2025.
- Over the past year, NVS quarterly accounts payable has increased by +$199.00 million (+4.90%).
- NVS quarterly accounts payable is now -30.69% below its all-time high of $6.15 billion, reached on December 31, 2013.
Performance
NVS quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
NVS Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.2% | +4.9% |
| 3 y3 years | -17.7% | -16.2% |
| 5 y5 years | -15.7% | -11.7% |
NVS Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -17.7% | at low | -21.5% | +10.1% |
| 5 y | 5-year | -17.7% | at low | -23.3% | +10.1% |
| alltime | all time | -25.6% | +363.7% | -30.7% | +349.0% |
NVS Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $4.26B(-6.8%) |
| Dec 2024 | $4.57B(-7.2%) | $4.57B(+11.9%) |
| Sep 2024 | - | $4.09B(-1.4%) |
| Jun 2024 | - | $4.15B(+2.1%) |
| Mar 2024 | - | $4.06B(-17.5%) |
| Dec 2023 | $4.93B(-4.3%) | $4.93B(+27.3%) |
| Sep 2023 | - | $3.87B(-27.7%) |
| Jun 2023 | - | $5.35B(-1.4%) |
| Mar 2023 | - | $5.43B(+5.4%) |
| Dec 2022 | $5.15B(-7.3%) | $5.15B(+9.7%) |
| Sep 2022 | - | $4.69B(-5.6%) |
| Jun 2022 | - | $4.97B(-2.2%) |
| Mar 2022 | - | $5.08B(-8.5%) |
| Dec 2021 | $5.55B(+2.8%) | $5.55B(+19.0%) |
| Sep 2021 | - | $4.67B(-3.0%) |
| Jun 2021 | - | $4.81B(-4.5%) |
| Mar 2021 | - | $5.04B(-6.7%) |
| Dec 2020 | $5.40B(-0.4%) | $5.40B(+14.8%) |
| Sep 2020 | - | $4.71B(-2.4%) |
| Jun 2020 | - | $4.82B(-0.2%) |
| Mar 2020 | - | $4.83B(-11.0%) |
| Dec 2019 | $5.42B(-2.4%) | $5.42B(+16.2%) |
| Sep 2019 | - | $4.67B(-1.7%) |
| Jun 2019 | - | $4.75B(+2.5%) |
| Mar 2019 | - | $4.64B(-16.5%) |
| Dec 2018 | $5.56B(+7.5%) | $5.56B(+11.8%) |
| Sep 2018 | - | $4.97B(-9.4%) |
| Jun 2018 | - | $5.49B(+9.9%) |
| Mar 2018 | - | $4.99B(-3.4%) |
| Dec 2017 | $5.17B(+6.1%) | $5.17B(+10.3%) |
| Sep 2017 | - | $4.68B(-0.1%) |
| Jun 2017 | - | $4.69B(+2.7%) |
| Mar 2017 | - | $4.57B(-6.3%) |
| Dec 2016 | $4.87B(-14.0%) | $4.87B(+4.5%) |
| Sep 2016 | - | $4.66B(-5.2%) |
| Jun 2016 | - | $4.92B(+4.6%) |
| Mar 2016 | - | $4.70B(-17.0%) |
| Dec 2015 | $5.67B(+4.6%) | $5.67B(+17.5%) |
| Sep 2015 | - | $4.83B(-5.9%) |
| Jun 2015 | - | $5.13B(+1.3%) |
| Mar 2015 | - | $5.06B(-6.6%) |
| Dec 2014 | $5.42B(-11.9%) | $5.42B(+19.9%) |
| Sep 2014 | - | $4.52B(-9.4%) |
| Jun 2014 | - | $4.99B(-9.0%) |
| Mar 2014 | - | $5.49B(-10.8%) |
| Dec 2013 | $6.15B | $6.15B(+21.0%) |
| Sep 2013 | - | $5.08B(+0.7%) |
| Jun 2013 | - | $5.04B(+3.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | $4.88B(-12.8%) |
| Dec 2012 | $5.59B(+12.1%) | $5.59B(+21.8%) |
| Sep 2012 | - | $4.59B(+0.1%) |
| Jun 2012 | - | $4.58B(+2.2%) |
| Mar 2012 | - | $4.49B(-10.1%) |
| Dec 2011 | $4.99B(+4.2%) | $4.99B(+13.6%) |
| Sep 2011 | - | $4.39B(-5.5%) |
| Jun 2011 | - | $4.64B(+3.3%) |
| Mar 2011 | - | $4.50B(-6.1%) |
| Dec 2010 | $4.79B(+19.3%) | $4.79B(+20.1%) |
| Sep 2010 | - | $3.99B(+13.6%) |
| Jun 2010 | - | $3.51B(-1.5%) |
| Mar 2010 | - | $3.56B(-11.2%) |
| Dec 2009 | $4.01B(+18.2%) | $4.01B(+22.5%) |
| Sep 2009 | - | $3.28B(-1.3%) |
| Jun 2009 | - | $3.32B(+1.8%) |
| Mar 2009 | - | $3.26B(-3.9%) |
| Dec 2008 | $3.40B(+12.5%) | $3.40B(+17.0%) |
| Sep 2008 | - | $2.90B(-10.7%) |
| Jun 2008 | - | $3.25B(+8.1%) |
| Mar 2008 | - | $3.01B(-0.4%) |
| Dec 2007 | $3.02B(+21.4%) | $3.02B(+10.8%) |
| Sep 2007 | - | $2.73B(+8.6%) |
| Jun 2007 | - | $2.51B(-2.6%) |
| Mar 2007 | - | $2.58B(+3.5%) |
| Dec 2006 | $2.49B(+26.8%) | $2.49B(+17.7%) |
| Sep 2006 | - | $2.11B(-3.8%) |
| Jun 2006 | - | $2.20B(+13.4%) |
| Mar 2006 | - | $1.94B(-1.3%) |
| Dec 2005 | $1.96B(-2.9%) | $1.96B(+10.6%) |
| Sep 2005 | - | $1.77B(-9.8%) |
| Jun 2005 | - | $1.97B(+6.6%) |
| Mar 2005 | - | $1.84B(-8.8%) |
| Dec 2004 | $2.02B(+21.3%) | $2.02B(+28.8%) |
| Sep 2004 | - | $1.57B(-3.8%) |
| Jun 2004 | - | $1.63B(+2.1%) |
| Mar 2004 | - | $1.60B(-4.1%) |
| Dec 2003 | $1.67B(+31.5%) | $1.67B(+27.3%) |
| Sep 2003 | - | $1.31B(-8.7%) |
| Jun 2003 | - | $1.43B(+11.3%) |
| Mar 2003 | - | $1.29B(+1.7%) |
| Dec 2002 | $1.27B(+15.9%) | $1.27B(+33.4%) |
| Sep 2002 | - | $949.00M(-7.6%) |
| Jun 2002 | - | $1.03B(-6.0%) |
| Dec 2001 | $1.09B(+10.8%) | $1.09B(+10.8%) |
| Dec 2000 | $986.00M(-20.4%) | $986.00M |
| Dec 1999 | $1.24B(+10.8%) | - |
| Dec 1998 | $1.12B | - |
FAQ
- What is Novartis AG annual accounts payable?
- What is the all time high annual accounts payable for Novartis AG?
- What is Novartis AG annual accounts payable year-on-year change?
- What is Novartis AG quarterly accounts payable?
- What is the all time high quarterly accounts payable for Novartis AG?
- What is Novartis AG quarterly accounts payable year-on-year change?
What is Novartis AG annual accounts payable?
The current annual accounts payable of NVS is $4.57B
What is the all time high annual accounts payable for Novartis AG?
Novartis AG all-time high annual accounts payable is $6.15B
What is Novartis AG annual accounts payable year-on-year change?
Over the past year, NVS annual accounts payable has changed by -$354.00M (-7.19%)
What is Novartis AG quarterly accounts payable?
The current quarterly accounts payable of NVS is $4.26B
What is the all time high quarterly accounts payable for Novartis AG?
Novartis AG all-time high quarterly accounts payable is $6.15B
What is Novartis AG quarterly accounts payable year-on-year change?
Over the past year, NVS quarterly accounts payable has changed by +$199.00M (+4.90%)